+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Collagen and HA-based Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • ID: 4911470
  • Report
  • October 2019
  • Region: Global
  • 158 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan plc
  • Anika Therapeutics, Inc.
  • BioCell Technology LLC
  • Collagen Solutions Plc
  • Sanofi
Collagen and HA-based Biomaterials Market - Scope of the Report

the report on the global collagen and HA-based biomaterials market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global collagen and HA-based biomaterials market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global collagen and HA-based biomaterials market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts have carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global collagen and HA-based biomaterials market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global collagen and HA-based biomaterials market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global collagen and HA-based biomaterials market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global collagen and HA-based biomaterials market. The next section of the global collagen and HA-based biomaterials report highlights the USPs, which include key mergers & acquisitions, technological advancements, major research institutes involved, pricing analysis, and key developments in the global collagen and HA-based biomaterials market.

The report delves into the competition landscape of the global collagen and HA-based biomaterials market. Key players operating in the global collagen and HA-based biomaterials market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOTs are some of the attributes of players in the global collagen and HA-based biomaterials market profiled in this report.

Key Questions Answered in Collagen and HA-based Biomaterials Market Report

  • What are the major drivers, restraints, and opportunities in the market?
  • What will be the revenue share projections of key segments in the global collagen and HA-based biomaterials market during the forecast period?
  • Which segment is likely to lead the global collagen and HA-based bio/materials market in terms of revenue by 2027?
  • How are mergers & acquisitions among players widening the scope for the global collagen and HA-based biomaterials market?
  • Which are the leading companies in the global collagen and HA-based biomaterials market?

Collagen and HA-based Biomaterials Market - Research Objectives and Research Approach

The comprehensive report on the global collagen and HA-based biomaterials market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, and healthcare compliances laid down by accredited agencies in the purview of research in the global collagen and HA-based biomaterials market. It is followed by market introduction, market dynamics, and an overview of the global collagen and HA-based biomaterials market, which includes an’s analysis of the market drivers, restraints, and trends affecting the growth of the global collagen and HA-based biomaterials market. Furthermore, to understand the Y-o-Y trends of the collagen and HA-based biomaterials market, a Y-o-Y analysis with elaborated insights on the same has been provided. The next section of the global collagen and HA-based biomaterials report highlights the USPs, which include key mergers & acquisitions, technological advancements, major research institutes involved, pricing analysis, and key industry developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of the actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan plc
  • Anika Therapeutics, Inc.
  • BioCell Technology LLC
  • Collagen Solutions Plc
  • Sanofi

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary : Global Collagen and HA-based Biomaterials Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Collagen and HA-based Biomaterials Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Key Industry Developments
5.2. Major Research Institutes Involved
5.3. Technological Advancements
5.4. Key Mergers & Acquisitions
5.5. Pricing Analysis
6. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Type
6.1. Introduction & Definition
6.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn)Forecast, by Type, 2017–2027
6.2.1. Urinary Incontinence
6.2.2. Corneal Shields
6.2.3. Facial Aesthetic Dermal Fillers
6.2.4. Wound Dressings
6.2.5. Others
6.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Type
7. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Application
7.1. Introduction
7.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
7.2.1. Food
7.2.2. Medicine
7.2.3. Cosmetics
7.2.4. Others
7.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Application
8. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Region
8.1. Introduction
8.2. Collagen and HA-based biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Region
9. North America Collagen and HA-based Biomaterials Market Analysis and Forecast
9.1. Introduction
9.2. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
9.2.1. Urinary Incontinence
9.2.2. Corneal Shields
9.2.3. Facial Aesthetic Dermal Fillers
9.2.4. Wound Dressings
9.2.5. Others
9.3. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
9.3.1. Food
9.3.2. Medicine
9.3.3. Cosmetics
9.3.4. Others
9.4. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Collagen and HA-based Biomaterials Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By Application
9.5.3. By Country/Sub-region
10. Europe Collagen and HA-based Biomaterials Market Analysis and Forecast
10.1. Introduction
10.2. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
10.2.1. Urinary Incontinence
10.2.2. Corneal Shields
10.2.3. Facial Aesthetic Dermal Fillers
10.2.4. Wound Dressings
10.2.5. Others
10.3. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.3.1. Food
10.3.2. Medicine
10.3.3. Cosmetics
10.3.4. Others
10.4. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Collagen and HA-based Biomaterials Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
11.2.1. Urinary Incontinence
11.2.2. Corneal Shields
11.2.3. Facial Aesthetic Dermal Fillers
11.2.4. Wound Dressings
11.2.5. Others
11.3. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.3.1. Food
11.3.2. Medicine
11.3.3. Cosmetics
11.3.4. Others
11.4. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Collagen and HA-based biomaterials Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
12.2.1. Urinary Incontinence
12.2.2. Corneal Shields
12.2.3. Facial Aesthetic Dermal Fillers
12.2.4. Wound Dressings
12.2.5. Others
12.3. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.3.1. Food
12.3.2. Medicine
12.3.3. Cosmetics
12.3.4. Others
12.4. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Collagen and HA-based biomaterials Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
13.2.1. Urinary Incontinence
13.2.2. Corneal Shields
13.2.3. Facial Aesthetic Dermal Fillers
13.2.4. Wound Dressings
13.2.5. Others
13.3. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.3.1. Food
13.3.2. Medicine
13.3.3. Cosmetics
13.3.4. Others
13.4. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Global Collagen and HA-based Biomaterials Market Share Analysis, by Company (2018)
14.3. Company Profiles
14.3.1. Collagen Solutions Plc
14.3.1.1. Company Description
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Sanofi
14.3.2.1. Company Description
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Allergan plc
14.3.3.1. Company Description
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Anika Therapeutics, Inc.
14.3.4.1. Company Description
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Bausch Health Companies Inc.
14.3.5.1. Company Description
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Abbott Laboratories
14.3.6.1. Company Description
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. Johnson & Johnson Services, Inc.
14.3.7.1. Company Description
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. Galderma Laboratories L.P. (Nestle Skin Health)
14.3.8.1. Company Description
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. BioCell Technology LLC
14.3.9.1. Company Description
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Collagen Solutions Plc
  • Sanofi
  • Allergan plc
  • Anika Therapeutics, Inc.
  • Bausch Health Companies Inc.
  • Abbott Laboratories
  • Johnson & Johnson Services, Inc.
  • Galderma Laboratories L.P. (Nestle Skin Health)
  • BioCell Technology LLC
Note: Product cover images may vary from those shown